Description

Dialipon Turbo (thioctic acid) solution for infusions 1.2% 50 ml. №10 vial

Ingredients

Active ingredient: Thioctic acid

Dosage

Recommended dosage: As directed by a healthcare professional. Typically administered intravenously.

Indications

Indicated for: Treatment of diabetic neuropathy and other conditions where thioctic acid supplementation is necessary.

Contraindications

Do not use if: Allergic to thioctic acid or any other ingredients in the solution.

Directions

Administration: Administered by healthcare professionals through intravenous infusion. Follow the healthcare provider’s instructions.

Scientific Evidence

Thioctic acid, the active ingredient in Dialipon Turbo, has shown promising results in clinical studies for its role in managing diabetic neuropathy. Research published in the journal *Diabetes Care* demonstrated that thioctic acid can improve neuropathic symptoms and nerve conduction in diabetic patients. Additionally, a meta-analysis published in *Current Pharmaceutical Design* highlighted the antioxidant and anti-inflammatory properties of thioctic acid, which can benefit various health conditions.

Additional Information

Thioctic acid, also known as alpha-lipoic acid, is a potent antioxidant that plays a crucial role in energy production within cells. It helps neutralize free radicals, reducing oxidative stress and inflammation in the body. Dialipon Turbo’s 1.2% solution for infusions ensures rapid and effective delivery of thioctic acid, making it a convenient option for patients requiring intravenous supplementation.

Thioctic acid’s pharmacological action involves enhancing glucose metabolism, improving insulin sensitivity, and protecting against cellular damage. Its ability to regenerate other antioxidants like vitamins C and E further contributes to its therapeutic benefits. Compared to conventional treatments, thioctic acid has shown superior efficacy in improving neuropathic symptoms and overall nerve health, making Dialipon Turbo a valuable addition to diabetic neuropathy management protocols.